Traumatic bone marrow lesions (BMLs) occur in ~80% of anterior cruciate ligament (ACL) injuries, typically in the lateral femoral condyle (LFC) and lateral tibial plateau (LTP). Associated with microfractures, vascular proliferation, inflammation, and bone density changes, BMLs may contribute to posttraumatic osteoarthritis. However, their relationship with knee pain is unclear. This study examined the prevalence, characteristics, and progression of BMLs after ACL injury, focusing on associations with pain, meniscal and ligament injuries, and fractures. Participants (N = 100, aged 14-55) with MRI-confirmed ACL tears were scanned within 6 weeks post-injury (mean = 30.0, SD = 9.6 days). BML volumes were quantified using a validated machine learning method, and pain assessed via the Knee Injury and Osteoarthritis Outcome Score (KOOS). Analyses included t-tests, Mann-Whitney U, chi-square, and Spearman correlations with false discovery rate correction. BMLs were present in 95% of participants, primarily in the LFC and LTP. Males had 33% greater volumes than females (p < 0.05), even after adjusting for BMI. Volumes were higher in cases with depression fractures (p = 0.022) and negatively associated with baseline KOOS Symptoms. At 1 year, 92.68% of lesions (based on lesion counts) resolved in Nonsurgical participants, with a 96.13% volume reduction (p < 0.001). KOOS outcomes were similar between groups, except for slightly better Pain scores in the Nonsurgical group. Baseline Pain and Sport scores predicted follow-up outcomes. BMLs are common post-ACL injury, vary by sex and fracture status, and modestly relate to early symptoms. Most resolve within a year, with limited long-term differences by surgical status.

Current machine learning-based (ML) models usually attempt to utilize all available patient data to predict patient outcomes while ignoring the associated cost and time for data acquisition. The purpose of this study is to create a multi-stage ML model to predict cardiac resynchronization therapy (CRT) response for heart failure (HF) patients. This model exploits uncertainty quantification to recommend additional collection of single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) variables if baseline clinical variables and features from electrocardiogram (ECG) are not sufficient. Two hundred eighteen patients who underwent rest-gated SPECT MPI were enrolled in this study. CRT response was defined as an increase in left ventricular ejection fraction (LVEF) > 5% at a 6 ± 1 month follow-up. A multi-stage ML model was created by combining two ensemble models: Ensemble 1 was trained with clinical variables and ECG; Ensemble 2 included Ensemble 1 plus SPECT MPI features. Uncertainty quantification from Ensemble 1 allowed for multi-stage decision-making to determine if the acquisition of SPECT data for a patient is necessary. The performance of the multi-stage model was compared with that of Ensemble models 1 and 2. The response rate for CRT was 55.5% (n = 121) with overall male gender 61.0% (n = 133), an average age of 62.0 ± 11.8, and LVEF of 27.7 ± 11.0. The multi-stage model performed similarly to Ensemble 2 (which utilized the additional SPECT data) with AUC of 0.75 vs. 0.77, accuracy of 0.71 vs. 0.69, sensitivity of 0.70 vs. 0.72, and specificity 0.72 vs. 0.65, respectively. However, the multi-stage model only required SPECT MPI data for 52.7% of the patients across all folds. By using rule-based logic stemming from uncertainty quantification, the multi-stage model was able to reduce the need for additional SPECT MPI data acquisition without significantly sacrificing performance.

Artificial intelligence (AI)-enabled multimodal cardiovascular imaging holds significant promise for improving diagnostic accuracy, enhancing risk stratification, and supporting clinical decision-making. However, its translation into routine practice remains limited by multiple technical, infrastructural, and clinical barriers. This review synthesizes current challenges, including variability in image quality, alignment, and acquisition protocols; scarcity of large, annotated multimodality datasets; interoperability limitations across vendors and institutions; clinical skepticism due to limited prospective validation; and substantial development and implementation costs. Drawing from recent advances, we outline future research priorities to bridge the gap between technical feasibility and clinical utility. Key strategies include developing unified, vendor-agnostic AI models resilient to inter-institutional variability; integrating diverse data types such as genomics, wearable biosensors, and longitudinal clinical records; leveraging reinforcement learning for adaptive decision-support systems; and employing longitudinal imaging fusion for disease tracking and predictive analytics. We emphasize the need for rigorous prospective clinical trials, harmonized imaging standards, and collaborative data-sharing frameworks to ensure robust, equitable, and scalable deployment. Addressing these challenges through coordinated multidisciplinary efforts will be essential to realize the full potential of AI-driven multimodal cardiovascular imaging in advancing precision cardiovascular care.

Neoadjuvant chemoimmunotherapy (NACI) regimen (camrelizumab plus paclitaxel and nedaplatin) has shown promising potential in patients with esophageal squamous cell carcinoma (ESCC), but accurately predicting the therapeutic response remains a challenge. To develop and validate a CT-based machine learning model that incorporates both intratumoral and peritumoral heterogeneity for predicting the pathological response of ESCC patients after NACI. Patients with ESCC who underwent surgery following NACI between June 2020 and July 2024 were included retrospectively and prospectively. Univariate and multivariate logistic regression analyses were performed to identify clinical variables associated with pathological response. Traditional radiomics features and habitat radiomics features from the intratumoral and peritumoral regions were extracted from post-treatment CT images, and six predictive models were established using 14 machine learning algorithms. The combined model was developed by integrating intratumoral and peritumoral habitat radiomics features with clinical variables. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). A total of 157 patients (mean [SD] age, 59.6 [6.5] years) were enrolled in our study, of whom 60 (38.2%) achieved major pathological response (MPR) and 40 (25.5%) achieved pathological complete response (pCR). The combined model demonstrated excellent predictive ability for MPR after NACI, with an AUC of 0.915 (95% CI, 0.844-0.981), accuracy of 0.872, sensitivity of 0.733, and specificity of 0.938 in the test set. In sensitivity analysis focusing on pCR, the combined model exhibited robust performance, with an AUC of 0.895 (95% CI, 0.782-0.980) in the test set. The combined model integrating intratumoral and peritumoral habitat radiomics features with clinical variables can accurately predict MPR in ESCC patients after NACI and shows promising potential in predicting pCR.

Deep-learning (DL) based MRI denoising techniques promise improved image quality and shorter examination times. This advancement is particularly beneficial for 0.55T MRI, where the inherently lower signal-to-noise (SNR) ratio can compromise image quality. Sufficient SNR is crucial for the reliable detection of vestibular schwannoma (VS). The objective of this study is to evaluate the VS conspicuity and acquisition time (TA) of 0.55T MRI examinations with contrast agents using a DL-denoising algorithm. From January 2024 to October 2024, we retrospectively included 30 patients with VS (9 women). We acquired a clinical reference protocol of the cerebellopontine angle containing a T1w fat-saturated (fs) axial (number of signal averages [NSA] 4) and a T1w Spectral Attenuated Inversion Recovery (SPAIR) coronal (NSA 2) sequence after contrast agent (CA) application without advanced DL-based denoising (w/o DL). We reconstructed the T1w fs CA sequence axial and the T1w SPAIR CA coronal with full DL-denoising mode without change of NSA, and secondly with 1 NSA for T1w fs CA axial and T1w SPAIR coronal (DL&1NSA). Each sequence was rated on a 5-point Likert scale (1: insufficient, 3: moderate, clinically sufficient; 5: perfect) for: overall image quality; VS conspicuity, and artifacts. Secondly, we analyzed the reliability of the size measurements. Two radiologists specializing in head and neck imaging performed the reading and measurements. The Wilcoxon Signed-Rank Test was used for non-parametric statistical comparison. The DL&4NSA axial/coronal study sequence achieved the highest overall IQ (median 4.9). The image quality (IQ) for DL&1NSA was higher (M: 4.0) than for the reference sequence (w/o DL; median 4.0 versus 3.5, each p < 0.01). Similarly, the VS conspicuity was best for DL&4NSA (M: 4.9), decreased for DL&1NSA (M: 4.1), and was lower but still sufficient for w/o DL (M: 3.7, each p < 0.01). The TA for the axial and coronal post-contrast sequences was 8:59 minutes for DL&4NSA and w/o DL and decreased to 3:24 minutes with DL&1NSA. This study underlines that advanced DL-based denoising techniques can reduce the examination time by more than half while simultaneously improving image quality.

This systematic review evaluates the effectiveness of artificial intelligence (AI) models in dental implant treatment planning, focusing on: 1) identification, detection, and segmentation of anatomical structures; 2) technical assistance during treatment planning; and 3) additional relevant applications. A literature search of PubMed/MEDLINE, Scopus, and Web of Science was conducted for studies published in English until July 31, 2024. The included studies explored AI applications in implant treatment planning, excluding expert opinions, guidelines, and protocols. Three reviewers independently assessed study quality using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Quasi-Experimental Studies, resolving disagreements by consensus. Of the 28 included studies, four were high, four were medium, and 20 were low quality according to the JBI scale. Eighteen studies on anatomical segmentation have demonstrated AI models with accuracy rates ranging from 66.4% to 99.1%. Eight studies examined AI's role in technical assistance for surgical planning, demonstrating its potential in predicting jawbone mineral density, optimizing drilling protocols, and classifying plans for maxillary sinus augmentation. One study indicated a learning curve for AI in implant planning, recommending at least 50 images for over 70% predictive accuracy. Another study reported 83% accuracy in localizing stent markers for implant sites, suggesting additional imaging planes to address a 17% miss rate and 2.8% false positives. AI models exhibit potential for automating dental implant planning with high accuracy in anatomical segmentation and insightful technical assistance. However, further well-designed studies with standardized evaluation parameters are required for pragmatic integration into clinical settings.

To assess the inter-rater reliability of ChatGPT-4 to that of orthopaedic surgery attendings and residents in classifying fractures on upper extremity (UE) and lower extremity (LE) radiographs. 84 radiographs of various fracture patterns were collected from publicly available online repositories. These images were presented to ChatGPT-4 with the prompt asking it to identify the view, body location, fracture type, and AO/OTA fracture classification. Two orthopaedic surgery residents and two attending orthopaedic surgeons also independently reviewed the images and identified the same categories. Fleiss' Kappa values were calculated to determine inter-rater reliability (IRR) for the following: All Raters Combined, AI vs. Residents (AIR); AI vs. Attendings (AIA); Attendings vs. Residents (AR). ChatGPT-4 achieved substantial to almost perfect agreement with clinicians on location (UE: κ = 0.655-0.708, LE: κ = 0.834-0.909) and fracture type (UE: κ = 0.546-0.563, LE: κ = 0.58-0.697). For view, ChatGPT-4 showed consistent fair agreement for both UE (κ = 0.370-0.404) and LE (κ = 0.309-0.390). ChatGPT-4 struggled the most with AO/OTA classification achieving slight agreement for UE (κ = -0.062-0.159) and moderate agreement for LE (κ = 0.418-0.455). IRR for AIR was consistently lower than IRR for AR. For AR comparisons, almost perfect agreement was observed for location (UE: κ = 0.896, LE: κ = 0.912) and fracture type (UE: κ = 0.948, LE: κ = 0.859), while AO/OTA classification showed fair agreement for UE (κ = 0.257) and moderate for LE (κ = 0.517). The p-values for all comparison groups were significant except for LE AO/OTA classification between AI and residents (p = 0.051). Although ChatcGPT-4 showed promise in classifying basic fracture features, it was not yet at a level comparable to experts, especially with more nuanced interpretations. These findings suggest that the use of AI is more effective as an adjunct to the judgment of trained clinicians rather than a replacement for it.

Lung ultrasound (LUS) has been widely used by point-of-care systems in both children and adult populations to provide different clinical diagnostics. This research aims to develop an interpretable system that uses a deep fusion network for classifying LUS video/patients based on extracted features by using texture analysis and transfer learning techniques to assist physicians. The pulmonary edema dataset includes 56 LUS videos and 4234 LUS frames. The COVID-BLUES dataset includes 294 LUS videos and 15,826 frames. The proposed multi-feature fusion classification network (MFFC-Net) includes the following: (1) two features extracted from Inception-ResNet-v2, Inception-v3, and 9 texture features of gray-level co-occurrence matrix (GLCM) and histogram of the region of interest (ROI); (2) a neural network for classifying LUS images with feature fusion input; and (3) four models (i.e., ANN, SVM, XGBoost, and kNN) used for classifying COVID/NON COVID patients. The training process was evaluated based on accuracy (0.9969), F1-score (0.9968), sensitivity (0.9967), specificity (0.9990), and precision (0.9970) metrics after the fivefold cross-validation stage. The results of the ANOVA analysis with 9 features of LUS images show that there was a significant difference between pulmonary edema and normal lungs (p < 0.01). The test results at the frame level of the MFFC-Net model achieved an accuracy of 100% and ROC-AUC (1.000) compared with ground truth at the video level with 4 groups of LUS videos. Test results at the patient level with the COVID-BLUES dataset achieved the highest accuracy of 81.25% with the kNN model. The proposed MFFC-Net model has 125 times higher information density (ID) compared to Inception-ResNet-v2 and 53.2 times compared with Inception-v3.

In the field of medical image analysis, medical image classification is one of the most fundamental and critical tasks. Current researches often rely on the off-the-shelf backbone networks derived from the field of computer vision, hoping to achieve satisfactory classification performance for medical images. However, given the characteristics of medical images, such as scattered distribution and varying sizes of lesions, features extracted with a single scale from the existing backbones often fail to perform accurate medical image classification. To this end, we propose a novel multi-scale learning paradigm, namely MUlti-SCale Learning with trusted Evidences (MUSCLE), which extracts and integrates features from different scales based on the theory of evidence, to generate the more comprehensive feature representation for the medical image classification task. Particularly, the proposed MUSCLE first estimates the uncertainties of features extracted from different scales/stages of the classification backbone as the evidences, and accordingly form the opinions regarding to the feature trustworthiness via a set of evidential deep neural networks. Then, these opinions on different scales of features are ensembled to yield an aggregated opinion, which can be used to adaptively tune the weights of multi-scale features for scatteredly distributed and size-varying lesions, and consequently improve the network capacity for accurate medical image classification. Our MUSCLE paradigm has been evaluated on five publicly available medical image datasets. The experimental results show that the proposed MUSCLE not only improves the accuracy of the original backbone network, but also enhances the reliability and interpretability of model decisions with the trusted evidences (https://github.com/Q4CS/MUSCLE).

Glioma, pituitary tumors, and meningiomas constitute the major types of primary brain tumors. The challenge in achieving a definitive diagnosis stem from the brain's complex structure, limited accessibility for precise imaging, and the resemblance between different types of tumors. An alternative and promising solution is the application of artificial intelligence (AI), specifically through deep learning models. We developed multiple lightweight deep learning models ResNet-18 (both pretrained on ImageNet and trained from scratch), ResNet-34, ResNet-50, and a custom CNN to classify glioma, meningioma, pituitary tumor, and no tumor MRI scans. A dataset of 7023 images was employed, split into 5712 for training and 1311 for validation. Each model was evaluated via accuracy, area under the curve (AUC), sensitivity, specificity, and confusion matrices. We compared our models to SOTA methods such as SAlexNet and TumorGANet, highlighting computational efficiency and classification performance. ResNet pretrained achieved 98.5-99.2% accuracy and near-perfect validation metrics, with an overall AUC of 1.0 and average sensitivity and specificity both exceeding 97% across the four classes. In comparison, ResNet-18 trained from scratch and the custom CNN achieved 91.99% and 87.03% accuracy, respectively, with AUCs ranging from 0.94 to 1.00. Error analysis revealed moderate misclassification of meningiomas as gliomas in non-pretrained models. Learning rate optimization facilitated stable convergence, and loss metrics indicated effective generalization with minimal overfitting. Our findings confirm that a moderately sized, transfer-learned network (ResNet-18) can deliver high diagnostic accuracy and robust performance for four-class brain tumor classification. This approach aligns with the goal of providing efficient, accurate, and easily deployable AI solutions, particularly for smaller clinical centers with limited computational resources. Future studies should incorporate multi-sequence MRI and extended patient cohorts to further validate these promising results.